Stefan Schwartz

发表

High rate of chromosome abnormalities detected by fluorescence in situ hybridization using BCR and ABL probes in adult acute lymphoblastic leukemia

E. Thiel, W. Ludwig, C. Fonatsch, 1998, Leukemia.

Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).

H. Gschaidmeier, M. Schmid, O. Ottmann, 2006, Blood.

Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).

H. Gschaidmeier, M. Schmid, O. Ottmann, 2006, Blood.

Molecular heterogeneity of sporadic adult Burkitt-type leukemia/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features

E. Thiel, H. Horst, H. Rieder, 2005, Leukemia.

Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).

H. Gschaidmeier, O. Ottmann, M. Bornhäuser, 2006, Blood.

Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF 2

C. Bartram, D. Gale, P. Maxwell, 2008 .

Molecular characterization of TCF3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment

T. Burmeister, N. Gökbuget, D. Gröger, 2023, Scientific reports.

Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols

P. Greif, S. Raffel, H. Trautmann, 2024, Leukemia.

Pegylated asparaginase in combination with high‐dose methotrexate for consolidation in adult acute lymphoblastic leukaemia in first remission: a pilot study

O. Rosen, T. Ittel, J. Boos, 2003, British journal of haematology.